About file location

As the EGA is co-managed by the EMBL-EBI and CRG, files could be located in the UK and/or Spain, as indicated by their respective flags.

Alternatively, files could be located in one of the international Federated EGA nodes, as indicated next to the node's flag.
Need Help?

March 2016 update of smRNA-Seq assays data (bam/fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency as part of the International Human Epigenome Consortium.

March 2016 update of smRNA-Seq assays data (bam/fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency as part of the International Human Epigenome Consortium.

Request Access

DUO:0000012
version: 2021-02-23

research specific restrictions

This data use modifier indicates that use is limited to studies of a certain research type.

DUO:0000025
version: 2021-02-23

time limit on use

This data use modifier indicates that use is approved for a specific number of months.

DUO:0000026
version: 2021-02-23

user specific restriction

This data use modifier indicates that use is limited to use by approved users.

DUO:0000027
version: 2021-02-23

project specific restriction

This data use modifier indicates that use is limited to use within an approved project.

BC Cancer, part of the Provincial Health Services Authority - Data Access Policy

Access to this data is controlled. There are a number of steps that a researcher must take to obtain access to this data, including execution of a Data Access Agreement between the institutions. The process is overseen by the Technology Development Office; please contact our general email address TDOadmin@phsa.ca. Please only click the "request data" button on the EGA website after a Data Access Agreement is fully executed.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001000552 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
i
EGAF00001082969 fastq.gz 32.0 MB Report
EGAF00001082970 fastq.gz 188.8 MB Report
EGAF00001082971 fastq.gz 142.3 MB Report
EGAF00001082972 fastq.gz 99.6 MB Report
EGAF00001082973 fastq.gz 195.3 MB Report
EGAF00001082974 fastq.gz 132.7 MB Report
EGAF00001082975 fastq.gz 112.3 MB Report
EGAF00001082976 fastq.gz 111.8 MB Report
EGAF00001082977 fastq.gz 195.8 MB Report
EGAF00001082978 fastq.gz 123.7 MB Report
EGAF00001082979 fastq.gz 212.4 MB Report
EGAF00001082980 fastq.gz 210.5 MB Report
EGAF00001082981 fastq.gz 130.4 MB Report
EGAF00001082982 fastq.gz 265.0 MB Report
EGAF00001082983 fastq.gz 237.2 MB Report
EGAF00001082984 fastq.gz 278.0 MB Report
EGAF00001082985 fastq.gz 29.3 MB Report
EGAF00001082986 fastq.gz 96.0 MB Report
EGAF00001082987 fastq.gz 96.9 MB Report
EGAF00001082988 fastq.gz 235.5 MB Report
EGAF00001110416 bam 32.0 MB Report
EGAF00001110417 bam 213.1 MB Report
EGAF00001110418 bam 210.7 MB Report
EGAF00001110419 bam 220.3 MB Report
EGAF00001110420 bam 193.9 MB Report
EGAF00001110421 bam 283.4 MB Report
EGAF00001110422 bam 251.7 MB Report
EGAF00001110423 bam 289.8 MB Report
EGAF00001110424 bam 245.0 MB Report
EGAF00001110425 bam 223.4 MB Report
EGAF00001110426 bam 151.6 MB Report
EGAF00001110427 bam 134.6 MB Report
EGAF00001110428 bam 115.0 MB Report
EGAF00001110429 bam 120.0 MB Report
EGAF00001110430 bam 130.8 MB Report
EGAF00001110431 bam 104.4 MB Report
EGAF00001110432 bam 101.2 MB Report
EGAF00001110434 bam 101.4 MB Report
EGAF00001110435 bam 135.7 MB Report
EGAF00001110436 bam 30.6 MB Report
40 Files (6.4 GB)